NexGel Q4 revenue up 181% to $3.04M, guides 2025 revenue of $13M, positive EBITDA

NEXGEL, INC.

Q4 revenue $3.04M (up 181% YoY); FY 2024 revenue $8.69M (up 112% YoY).
Gross margin improved to 37.2% in Q4 vs 8.7% a year ago; net loss narrowed to $0.85M from $1.10M.
Cash $1.81M at Dec 31, 2024; guides Q1 2025 revenue at least $2.75M, FY 2025 revenue $13M and positive EBITDA.
Operational: first SilverSeal shipments to Cintas; Silly George run rate >$5M; Stada Histasolv launched.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.